$6.80 0.09 (+1.34%)
11/6/2009 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating: 5 out of 5

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Current Price $6.80 Mkt Cap $730.23M
Open $6.61 P/E Ratio 0.00
Prev. Close $6.71 Div. (Yield) N/A (N/A)
Daily Range $6.55 - $6.81 Volume 754,387
52-Wk Range $2.11 - $7.25 Avg. Daily Vol. 847,000

EXEL News and Commentary

View All EXEL News and Commentary

Caps

How do you think EXEL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

2,260 Outperform
81 Underperform
 

All-Star Members

621 Outperform
24 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top EXEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jbonds (88.01)
Submitted May 28, 2009

Exelixis and Sanofi-Aventis sign global license agreement for XL147 & XL765 and launch collaboration for discovery of PI3K inhibitors Sanofi-Aventis (SNY) and co announce a global license agreement for XL147 and XL765 and a collaboration for the… More

BRADYstocks (63.09)
Submitted February 26, 2008

This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.

EXEL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about EXEL.

Recs

0
Member Avatar tonyrjohnson (54.92) Submitted: 11/3/2009 1:32:11 PM : Outperform Start Price: $6.68 EXEL Score: -0.89

Good list of products. Good partners. good long term play

Recs

0
Member Avatar stockfreak1 (< 20) Submitted: 10/30/2009 2:41:14 AM : Underperform Start Price: $5.71 EXEL Score: -18.31

sucking afterhours.

Recs

0
Member Avatar fourthreethree (55.59) Submitted: 10/13/2009 1:22:31 PM : Outperform Start Price: $6.25 EXEL Score: +9.09

I'm speculating that this company may have something good cooking in one of their labs and the street is apparently detecting a delectable dining experience. How horrible is that metaphor?

Leaderboard

Find the members with the highest scoring picks in EXEL.

Score Leader

Nordaak

Nordaak (97.58) Score: +146.13

The Score Leader is the member with the highest score across all their picks in EXEL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
Nordaak 97.58 11/21/2008 Outperform NS $2.34 +190.60% +44.46% +146.13
Renegadecj 75.85 11/24/2008 Outperform 5Y $2.50 +172.00% +31.90% +140.10
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. BringUs 84.87 11/26/2008 Outperform NS $2.56 +165.62% +30.30% +135.32
TRock1081 97.86 11/24/2008 Outperform 5Y $2.57 +164.59% +31.27% +133.33
botso < 20 11/21/2008 Outperform 5Y $2.48 +174.19% +44.48% +129.71
massexile < 20 11/24/2008 Outperform 1Y $2.71 +150.92% +33.82% +117.10
trsteff 24.16 11/25/2008 Outperform 5Y $2.91 +133.68% +25.80% +107.87
nvmk < 20 11/25/2008 Outperform 1Y $2.91 +133.68% +25.80% +107.87
MattH42004 99.91 10/29/2008 Outperform 5Y $3.02 +125.17% +17.76% +107.41 1 Comment
SlotRacer 74.04 10/30/2008 Outperform 1Y $3.11 +118.65% +14.41% +104.24 2 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackIcahn 27.08 2/24/2009 Outperform 1Y $4.69 +44.99% +44.81% +0.18 1 Comment
TrackMerriman < 20 10/16/2008 Outperform NS $4.15 +63.86% +20.07% +43.79
TrackCanaccord 84.17 7/8/2008 Outperform NS $5.19 +12.91% +1.82% +11.08 8/6/2008 @ $5.86
TrackSoros 65.62 3/31/2008 Outperform NS $6.95 -2.16% -15.82% +13.66 1 Comment
TrackEveillard 89.92 12/31/2007 Outperform NS $8.63 -21.21% -23.64% +2.43 1 Comment
TrackLazardCapit < 20 9/14/2007 Outperform NS $10.44 -34.87% -24.00% -10.86

Featured Broker Partners